Castle Biosciences, Inc. Rings the Closing Bell

About This Event

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Derek Maetzold, President and Chief Executive Officer of Castle Biosciences, rings the Closing Bell to raise awareness of melanoma in honor of patients impacted by the disease.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore